1. Home
  2. MICC vs RGEN Comparison

MICC vs RGEN Comparison

Compare MICC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MICC

The Magnum Ice Cream Company N.V. Ordinary Shares

N/A

Current Price

$19.29

Market Cap

12.1B

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$173.92

Market Cap

11.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MICC
RGEN
Founded
2025
1981
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Specialty Foods
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1B
11.0B
IPO Year
2025
1995

Fundamental Metrics

Financial Performance
Metric
MICC
RGEN
Price
$19.29
$173.92
Analyst Decision
Hold
Buy
Analyst Count
4
22
Target Price
$19.08
★ $201.45
AVG Volume (30 Days)
725.1K
★ 1.1M
Earning Date
10-30-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 286.96
EPS
N/A
★ 0.24
Revenue
N/A
★ $141,236,000.00
Revenue This Year
$5.51
$13.28
Revenue Next Year
$4.03
$29.14
P/E Ratio
★ $28.55
$743.71
Revenue Growth
N/A
★ 35.10
52 Week Low
$12.94
$100.99
52 Week High
$20.69
$198.87

Technical Indicators

Market Signals
Indicator
MICC
RGEN
Relative Strength Index (RSI) 58.32 47.72
Support Level $18.83 $158.62
Resistance Level $19.92 $187.36
Average True Range (ATR) 0.35 8.14
MACD 0.20 -0.41
Stochastic Oscillator 83.30 61.26

Price Performance

Historical Comparison
MICC
RGEN

About MICC The Magnum Ice Cream Company N.V. Ordinary Shares

The Magnum Ice Cream Company is a spinoff from Unilever, a pure-play company in manufacturing and selling a broad portfolio of ice-cream brands. The company is a global category leader, operating in 80 countries with around 21% market share. TMICC owns four of the world's five largest ice-cream brands: the Heartbrand (an "umbrella" brand with numerous well-known subbrands, which constitutes around 35% of sales), Magnum (23%), Ben & Jerry's (14%), and Cornetto (9%). The business generates about 65% of its revenue in developed markets, with the balance coming from emerging markets.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: